286 related articles for article (PubMed ID: 31070352)
1. Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma.
Chai Z; Ran D; Lu L; Zhan C; Ruan H; Hu X; Xie C; Jiang K; Li J; Zhou J; Wang J; Zhang Y; Fang RH; Zhang L; Lu W
ACS Nano; 2019 May; 13(5):5591-5601. PubMed ID: 31070352
[TBL] [Abstract][Full Text] [Related]
2. All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment.
Ding Y; Xu Q; Chai Z; Wu S; Xu W; Wang J; Zhou J; Luo Z; Liu Y; Xie C; Lu L; Lu W
J Control Release; 2024 May; 369():325-334. PubMed ID: 38565395
[TBL] [Abstract][Full Text] [Related]
3. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
4. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery.
Chai Z; Hu X; Wei X; Zhan C; Lu L; Jiang K; Su B; Ruan H; Ran D; Fang RH; Zhang L; Lu W
J Control Release; 2017 Oct; 264():102-111. PubMed ID: 28842313
[TBL] [Abstract][Full Text] [Related]
5. Glioma targeting peptide modified apoferritin nanocage.
Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
[TBL] [Abstract][Full Text] [Related]
6. Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy.
Chen M; Cui Y; Hao W; Fan Y; Zhang J; Liu Q; Jiang M; Yang Y; Wang Y; Gao C
Drug Deliv; 2021 Dec; 28(1):2241-2255. PubMed ID: 34668811
[TBL] [Abstract][Full Text] [Related]
7. A d-Peptide Ligand of Integrins for Simultaneously Targeting Angiogenic Blood Vasculature and Glioma Cells.
Ren Y; Zhan C; Gao J; Zhang M; Wei X; Ying M; Liu Z; Lu W
Mol Pharm; 2018 Feb; 15(2):592-601. PubMed ID: 29283582
[TBL] [Abstract][Full Text] [Related]
8. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.
Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity.
Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q
J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502
[TBL] [Abstract][Full Text] [Related]
10. Platelet-Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma.
Wu L; Li Q; Deng J; Shen J; Xu W; Yang W; Chen B; Du Y; Zhang W; Ge F; Lei S; Li K; Wang Z
Int J Nanomedicine; 2021; 16():8433-8446. PubMed ID: 35002237
[TBL] [Abstract][Full Text] [Related]
11. A stabilized peptide ligand for multifunctional glioma targeted drug delivery.
Ying M; Shen Q; Zhan C; Wei X; Gao J; Xie C; Yao B; Lu W
J Control Release; 2016 Dec; 243():86-98. PubMed ID: 27693752
[TBL] [Abstract][Full Text] [Related]
12. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
[TBL] [Abstract][Full Text] [Related]
13. Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.
Chi Y; Zhu S; Wang C; Zhou L; Zhang L; Li Z; Dai Y
J Drug Target; 2016; 24(3):224-32. PubMed ID: 26219518
[TBL] [Abstract][Full Text] [Related]
14. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
15. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.
Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y
J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302
[TBL] [Abstract][Full Text] [Related]
17. Stabilized Heptapeptide A7R for Enhanced Multifunctional Liposome-Based Tumor-Targeted Drug Delivery.
Ying M; Shen Q; Liu Y; Yan Z; Wei X; Zhan C; Gao J; Xie C; Yao B; Lu W
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13232-41. PubMed ID: 27195531
[TBL] [Abstract][Full Text] [Related]
18. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.
Gao H; Zhang S; Cao S; Yang Z; Pang Z; Jiang X
Mol Pharm; 2014 Aug; 11(8):2755-63. PubMed ID: 24983928
[TBL] [Abstract][Full Text] [Related]
19. Multi-functional peptide-modified liposomes for treatment of glioma.
Park K
J Control Release; 2018 Nov; 289():171. PubMed ID: 30724172
[No Abstract] [Full Text] [Related]
20. Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma.
Fan Y; Hao W; Cui Y; Chen M; Chu X; Yang Y; Wang Y; Gao C
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
